Global Cannabis and CBD News Roundup YouTube

The CBD market is feeling the pinch while everyone waits for FDA or Congress to provide clarity.

We have some data on what Big Pharma has known for a while: they lose market share when cannabis is legalized in a state. While they have lobbied against cannabis for quite some time, I expect to see more enter the market as Pfizer did in December with a $6.7B purchase.

Panama’s president decreed that the country will for the first time regulate medicinal cannabis. Manuel Noriega, eat your heart out! Sorry, just a little bit of Iran-Contra humor there. :)

And speaking of International playboys, excessively flamboyant Dan Bilzerian’s company, Ignite, is being sued by regulators.

Feel free to subscribe to our Cannabis or CBD News Roundups.

Have an incredible week!

Weekly News
Pharmaceutical Industry Suffers Billions in Losses after States Legalize Cannabis, New Study Finds More at
Sec Sues Dan Bilzerian’s Ignite, Discloses Criminal Investigation More at
Panama Regulates the Medicinal Use of Cannabis More at
Here’s How Fentanyl Can Affect Your Brain – And Breathing More at
A Dozen California Cannabis Bills Head To Governor More at
Applications for Recreational Cannabis Licenses Open in Detroit More at
Jamaica: OGH Hemp Farm Fails … Land Goes Back to Standard Agricultural Products More at
Top CBD Companies Experience Market Share Drop as Online Sales Soften More at
California Q2 Cannabis Sales Up, Taxes Trend Down More at
Pot Prohibitionists Fear Democracy More than Cannabis More at
Cannabis Is Radioactive Enough. Grow It Outdoors to Keep Diablo Canyon’s Closure on Schedule More at
What You Need to Know to Sell Medical Cannabis in Alabama. Application Period Started Thursday. More at
Green Organic Dutchman Throws Stock at Debt, Viridian Smells Recession More at
Why Weed Companies Can’t Make Any Money More at
Cool Finds
A Social History of America’s Most Popular Drugs More at
Panama’s Ex Dictator Manuel Noriega: CIA Spy Turned Drug-Running Dictator More at
Stocks and Startups Briefs

Khiron Life Sciences Corp. (TSXV: KHRN, OTCQX: KHRNF) posted Q2 results, down from last year.
Cansortium (CSE: TIUM.U) revenue increased 36% to $22.4M in Q2 compared with last year’s $16.5M.
Entourage Health (OTCQX: ETRGF, TSXV: ENTG) had a Q2 revenue dip, at $13.2M, down 5% from last year.
Jushi Holdings (CSE: JUSH, OTCQX: JUSHF) reported a Q2 revenue increased of 52.4% to $72.8M.
RIV Capital (CSE: RIV, OTC: CNPOF) released Q1 results of $1.4M in revenue versus $3.4M net losses.

Flower One (CSE: FONE, OTCQB: FLOOF) has missed expectations for the quarter.
Wesana Health (CSE: WESA, OTCQB: WSNAF) shared that it has reduced its annual operating expenses by more than $2.1M.
PharmaCielo released Q2 financial results showing continued sales growth.
The 1937 Group , identified as the first minority-owned cannabis company in Illinois, has secured $17M in funding.
Red White & Bloom Brands reports Q2 results.

Emerald Health Therapeutics (CSE: EMH) (OTCQB: EMHTF) reported financial results for the year.
Leviathan Natural Products completed the sale of its 100% interest in Woodstock Biomed for $5M.

Green Organic Dutchman (CSE: TGOD) (OTC: TGODF) organized to issue 937,500 shares at $0.08 per share in $75,000 debt settlement.
Glass House Brands (NEO: GLAS.A.U) (NEO: GLAS.WT.U) (OTCQX: GLASF) closed its first tranche of a nonbrokered private placement of Series B Preferred Stock for $50M.
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis, announced that director and principal shareholder Derek Stern, acquired 720,000 common shares.
BudBlockz provides an opportunity to invest Bitcoin (BTC), Ethereum (ETH) and BNB in the cannabis industry.